Peter Bettelheim focuses on Immunology, Myeloid, Molecular biology, Internal medicine and Monoclonal antibody. He has included themes like Haematopoiesis, Cellular differentiation and Induction chemotherapy in his Immunology study. His Myeloid research incorporates elements of European LeukemiaNet, Oncology and Bone marrow.
The Molecular biology study combines topics in areas such as Cell culture and Stem cell factor. Peter Bettelheim interconnects Diabetes mellitus and Endocrinology in the investigation of issues within Internal medicine. His Monoclonal antibody research is multidisciplinary, incorporating perspectives in Precursor cell and Antigen.
Peter Bettelheim mainly investigates Immunology, Internal medicine, Leukemia, Myeloid and Antigen. Peter Bettelheim combines subjects such as Progenitor cell and Haematopoiesis with his study of Immunology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
His Endocrinology research incorporates themes from Interleukin 3 and Blood coagulation test. His studies in Myeloid integrate themes in fields like Acute myeloblastic leukemia and Precursor cell. As part of the same scientific family, Peter Bettelheim usually focuses on Antibody, concentrating on Platelet and intersecting with Autoantibody.
His primary areas of study are Myelodysplastic syndromes, Cancer research, Internal medicine, Myeloid and Chronic myelomonocytic leukemia. His work carried out in the field of Myelodysplastic syndromes brings together such families of science as Aplastic anemia, European LeukemiaNet, Anemia and Intensive care medicine. His Cancer research research includes elements of Leukemia, Stem cell, Antigen and CD38.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology. His Myeloid study is associated with Immunology. His work in Immunology is not limited to one particular discipline; it also encompasses Haematopoiesis.
Peter Bettelheim mainly investigates Myelodysplastic syndromes, Leukemia, Pathology, Erythroid dysplasia and Myeloid leukemia. The various areas that Peter Bettelheim examines in his Myelodysplastic syndromes study include Anemia, Intensive care medicine, Bone marrow neoplasm, European LeukemiaNet and Flow cytometry. The subject of his Leukemia research is within the realm of Immunology.
The study incorporates disciplines such as Medical physics and Confidence interval in addition to Pathology. His work is dedicated to discovering how Myeloid leukemia, Neoplastic cell are connected with Cancer research and other disciplines. His study explores the link between Cancer research and topics such as Cell culture that cross with problems in Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals
Rudolf Valenta;Michael Duchêne;Karin Pettenburger;Christian Sillaber.
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
Peter Valent;Eva Spanblochl;Wolfgang R. Sperr;Christian Sillaber.
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
Robert Pirker;Josef Wallner;Klaus Geissler;Werner Linkesch.
Journal of the National Cancer Institute (1991)
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.
P Valent;LK Ashman;W Hinterberger;F Eckersberger.
Interleukin-3 is a differentiation factor for human basophils.
P Valent;G Schmidt;J Besemer;P Mayer.
Interleukin 3 activates human blood basophils via high-affinity binding sites.
P Valent;J Besemer;M Muhm;O Majdic.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Cell Surface Structures on Human Basophils and Mast Cells: Biochemical and Functional Characterization
Peter Valent;Peter Bettelheim.
Advances in Immunology (1992)
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
P Bettelheim;P Valent;M Andreeff;A Tafuri.
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.
T. M. Westers;Robin M Ireland;W. Kern;C. Alhan.
Glycosylated hemoglobins (GHb): an index of red cell survival.
S Panzer;G Kronik;K Lechner;P Bettelheim.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: